Moderna, Rovi to collaborate on fill-finish manufacturing of mRNA-1273

Moderna and Laboratorios Farmacéuticos Rovi have entered into a collaboration for large-scale, commercial fill-finish manufacturing of mRNA-1273, the former's mRNA vaccine candidate against COVID-19, at ... Read More